Compare NKTX & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | JILL |
|---|---|---|
| Founded | 2015 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.9M | 188.7M |
| IPO Year | 2020 | 2017 |
| Metric | NKTX | JILL |
|---|---|---|
| Price | $3.14 | $12.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $11.33 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 749.2K | 51.6K |
| Earning Date | 05-11-2026 | 06-10-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 11.88 | N/A |
| EPS | N/A | ★ 1.82 |
| Revenue | N/A | ★ $596,549,000.00 |
| Revenue This Year | N/A | $2.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.63 | $10.41 |
| 52 Week High | $3.65 | $18.80 |
| Indicator | NKTX | JILL |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 52.28 |
| Support Level | $1.88 | $12.02 |
| Resistance Level | $3.35 | $12.71 |
| Average True Range (ATR) | 0.21 | 0.59 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 74.00 | 57.21 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). J.Jill caters to a distinctive set of women, typically forty-five years and older, offering them various apparel products, footwear, and accessories, comprising shirts, dresses, tops and tees, sweaters, pants and jeans, jewelry, bags, belts, shoes, scarves, etc. The company's operating segments consist of its Retail channels, which derive maximum revenue, and Direct channels. Geographically, the majority of its revenue is derived from the United States.